Point72 Asset Management »

Jade Biosciences shares owned by Point72 Asset Management

Quarter-by-quarter ownership of Jade Biosciences (JBIO) shares owned by Point72 Asset Management from 13F filings

Historical chart of Point72 Asset Management investment in Jade Biosciences

Tip: Access up to 7 years of quarterly data

All positions including Jade Biosciences held by Point72 Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Jade Biosciences by Point72 Asset Management

Quarter filed Position value Share count Share price at filing
2025-12-31 $8.6M 559k 15.43

More positions owned by Point72 Asset Management

Spdr S&p 500 Etf Tr Tr Unit Call Option (SPY)
NVIDIA Corporation (NVDA)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Taiwan Semiconductor Mfg Sponsored Ads (TSM)
Amazon (AMZN)
Broadcom (AVGO)
Arista Networks Com Shs (ANET)
Microsoft Corporation (MSFT)
Credo Technology Group Holdi Ordinary Shares (CRDO)
Asml Holding N V N Y Registry Shs (ASML)
Spotify Technology S A SHS (SPOT)
Sea Sponsord Ads (SE)
Biogen Idec (BIIB)
Equinix (EQIX)
Coherent Corp (COHR)

View all positions for Point72 Asset Management

Top funds holding Jade Biosciences

FMR
Fairmount Funds Management
Bellevue Group
VR Adviser
BlackRock
Vanguard Group
Versant Venture Management
Rtw Investments
Avidity Partners Management
Driehaus Capital Management
RA Capital Management
Samsara BioCapital
Marshall Wace
Standard Life Aberdeen
Geode Capital Management

View all funds holding Jade Biosciences